All patients (N = 130) | OR | 95% CI | p | AUC | 95% CI AUC | H-L test p-value |
---|---|---|---|---|---|---|
Model “QRS ≥ 160ms” (45 outcomes) | 0.74 | (0.65 to 0.83) | 0.9082 | |||
RVESVi ≥ 65 ml/m2 | 2.85 | (1.25 to 6.50) | 0.013 | |||
RA area (cm2) | 1.06 | (1.01 to 1.11) | 0.021 | |||
Male | 3.12 | (1.38 to 7.07) | 0.006 | |||
Model “Pharmacological therapy” (37 outcomes) | 0.89 | (0.82 to 0.96) | 0.7526 | |||
Time from repair to CMR (years) | 1.10 | (1.04 to 1.16) | 0.001 | |||
Age at TOF repair (months) | 1.02 | (1.01 to 1.03) | < 0.001 | |||
IVS LGE (cm) | 1.47 | (1.04 to 2.10) | 0.031 |